C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2004
10/28/2004	US20040215017 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite
10/28/2004	US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004	US20040214899 aqueous solutions of citric acid, disodium phosphate and (S)-4-{{3-[2-(dimethylaminoethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, used for prophylaxis of headaches; drug delivery devices; nasal sprays
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214870 Protein-tyrosine phosphatase inhibitors and uses thereof
10/28/2004	US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004	US20040214868 Treatment or prevention of type 2 diabetes; chemical synthesis; 2-[ benzoyl]aminopyridine-5-carboxylate derivatives
10/28/2004	US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004	US20040214841 Quinazoline derivatives for treatment of tumours
10/28/2004	US20040214832 Piperazine derivative renin inhibitors
10/28/2004	US20040214828 the agronomic pesticide is combined with surfactants and solid or liquid diluents, and optionally combined with another active ingredient; nontoxic
10/28/2004	US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/28/2004	US20040214818 Alzheimer's disease; Parkinson's disease; Huntington's disease; cognition activators; learning enhancement; central nervous system disorders
10/28/2004	US20040214817 Diaminotriazoles useful as inhibitors of protein kinases
10/28/2004	US20040214816 Substituted imidazoles useful in the treatment of inflammatory diseases
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214746 Pharmaceutical composition of a tachykinin receptor antagonist
10/28/2004	US20040214251 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay
10/28/2004	US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light
10/28/2004	US20040214036 Electron transport agents for organic electronic devices
10/28/2004	CA2527170A1 Therapeutic compounds
10/28/2004	CA2522195A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521915A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004	CA2521619A1 Aminoquinoline compounds
10/28/2004	CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	CA2521135A1 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
10/28/2004	CA2520804A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004	CA2520323A1 Tie-2 modulators and methods of use
10/28/2004	CA2520259A1 Cxcr4 chemokine receptor binding compounds
10/27/2004	EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor
10/27/2004	EP1471065A1 Novel 1,2,4-triazole compound
10/27/2004	EP1471060A1 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470825A1 Reagents for detecting efavirenz
10/27/2004	EP1470137A1 Edg receptor agonists
10/27/2004	EP1470123A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, related compositions and methods
10/27/2004	EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors
10/27/2004	EP1470119A1 Benzothiophene compounds having antiinfective activity
10/27/2004	EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators
10/27/2004	EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/27/2004	EP1037629B1 Combination of a retinoic acid metabolism blocking agent and a tocophereol
10/27/2004	CN1541215A HIV inhibiting pyrimidines derivatives
10/27/2004	CN1541214A Novel compounds
10/27/2004	CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004	CN1541206A Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use
10/27/2004	CN1541205A Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/27/2004	CN1541096A Compounds which mimic chemical and biological properties of discodermolide
10/27/2004	CN1541063A Method for controlling particular insects by applying anthranilamide compounds
10/27/2004	CN1539837A Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)
10/27/2004	CN1539834A Method for preparing handy amino-tetrahydrofurans or its salts
10/27/2004	CN1539832A Process for preparing oxazolines from tetrahydrofurans
10/27/2004	CN1172917C Steroid receptor modulator compounds and methods
10/26/2004	US6809111 Antiinflammatory agents; analgesics
10/26/2004	US6809107 Neurodegenerative diseases
10/26/2004	US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis
10/26/2004	US6809095 Novel antitobesity and hypocholesterolemic compounds lower total cholesterol; increase high density lipoprotein (hdl) and decrease low denstiy lipoprotein
10/26/2004	CA2211534C Isoxazolyl-benzoyl derivatives
10/26/2004	CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
10/22/2004	CA2465017A1 Reagents for detecting efavirenz
10/21/2004	WO2004089947A2 Novel compounds having an antibacterial activity
10/21/2004	WO2004089944A1 Oxazolidinone derivatives as antimicrobials
10/21/2004	WO2004089943A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
10/21/2004	WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents
10/21/2004	WO2004089937A1 7-membered heterocyclic derivative
10/21/2004	WO2004089932A1 Substituted pyrazole compounds
10/21/2004	WO2004089931A1 Substituted pyrazoles
10/21/2004	WO2004089925A1 Pi-3 kinase inhibitor prodrugs
10/21/2004	WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof
10/21/2004	WO2004089915A1 Piperazine derivative renin inhibitors
10/21/2004	WO2004089913A1 Aminopyrimidine derivatives and their medical use
10/21/2004	WO2004089882A2 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
10/21/2004	WO2004089368A1 Therapeutic or preventive agent for dermatitis
10/21/2004	WO2004076407A3 Pyrrolidine derivatives as oxytocin antagonists
10/21/2004	WO2004069832A3 Antibacterial agents
10/21/2004	WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/21/2004	WO2004056786A3 Pyrimidine derivates for the treatment of abnormal cell growth
10/21/2004	WO2004048350A3 Oxazolidinones as antibacterial agents
10/21/2004	WO2004014370A3 Oxadiazoles as modulators of metabotropic glutamate receptor-5
10/21/2004	US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004	US20040209948 especially naphthalene sulfonamides, used for treating asthma
10/21/2004	US20040209936 Compounds that modulate PPAR activity and methods of preparation
10/21/2004	US20040209933 containing a p-[4-(1H-[1,2,3]triazolyl)butyl]phenoxymethyl group, e.g., 1-(4-{4-[2-(2-Benzo[1,3]dioxol-5-yl-vinyl)-oxazol-4-ylmethoxy]-phenyl}-butyl)-1H-[1,2,3]triazole or salt; anticancer agents
10/21/2004	US20040209932 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
10/21/2004	US20040209929 Fused heteroaryl carboxylic acids as PPAR agonists
10/21/2004	US20040209924 treatment of prostate or breast cancer
10/21/2004	US20040209921 CXCR4 chemokine receptor binding comounds
10/21/2004	US20040209920 Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
10/21/2004	US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
10/21/2004	US20040209912 Substituted isoquinoline derivatives and their use as anticonvulsants
10/21/2004	US20040209902 Aminoquinoline compounds
10/21/2004	US20040209892 Heterocyclic compounds and methods of use
10/21/2004	US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
10/21/2004	US20040209882 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
10/21/2004	US20040209881 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
10/21/2004	US20040209880 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation.
10/21/2004	US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity

1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 647